Exploiting Metabolic Vulnerabilities in Cancer with a Dual-Transporter-Targeted 2-Deoxyglucose Analogue for Low-Dose, Potent Antitumor Activity. - Jeon S; Qin X; Hildebrand MA; Odom TL; Zamborini I; Patel R; Liu X; Seo C; Callmann CE (Journal of the American Chemical Society, 2025)